InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 748

Wednesday, 04/04/2018 1:32:16 PM

Wednesday, April 04, 2018 1:32:16 PM

Post# of 1162
NKTR-214 JV clears HSR review—BMY can now start enrolling patients in multiple pivotal trials of Opdivo + NKTR-214, as previously described:

https://www.prnewswire.com/news-releases/nektar-therapeutics-announces-effective-date-of-global-development--commercialization-collaboration-with-bristol-myers-squibb-300623904.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News